Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer

Objective: To analyze adverse reactions in patients with nonmetastatic colorectal cancer due to treatment with either innovative or generic capecitabine and/or to the chemotherapeutic regimen employed, to the capecitabine alone, or in combination with oxaliplatin (XELOX).Method: Descriptive retros...

Descripció completa

Dades bibliogràfiques

Publicat a:	Farmacia Hospitalaria
Autors principals:	Julia Sánchez-Gundín, Ana-Isabel Torres-Suárez, Ana-María Fernández-Carballido, Dolores Barreda-Hernández
Format:	Artigo
Idioma:	Inglês
Publicat:	Sociedad Española de Farmacia Hospitalaria 2019
Matèries:	Medicina
Accés en línia:	https://www.redalyc.org/articulo.oa?id=365961518001 https://www.redalyc.org/journal/3659/365961518001/ https://www.redalyc.org/journal/3659/365961518001/html/ https://www.redalyc.org/journal/3659/365961518001/365961518001.epub https://www.redalyc.org/journal/3659/365961518001/movil
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!